US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 25.000
  • +1.040+4.34%
Close Sep 27 16:00 ET
  • 25.000
  • 0.0000.00%
Post 16:09 ET
1.78BMarket Cap-166666P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiniksa Pharmaceuticals International Q2 2024 Earnings Date

Currency：USDJul 23, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
91.27M
108.63M
+17.36M
Beat Est.
+27.69%
+51.99%
+19.03%
EPS
-0.05
-0.06
-<0.01
Miss Est.
-125.48%
-128.57%
-12.15%
Analyst Rating
Strong Buy

Sep 13, 2024

Kiniksa Pharmaceuticals International Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 122.143M--
--2024/Q3-- / 110.584M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
Feb 28, 20242023/Q483.395M / 72.272M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 122.143M--
--2024/Q3-- / 110.584M--
Jul 23, 20242024/Q2108.631M / 91.266M--
Apr 23, 20242024/Q179.858M / 78.464M--
Feb 28, 20242023/Q483.395M / 72.272M--

Unlock Free Earnings Estimates

Kiniksa Pharmaceuticals International Earnings Reports

  • Kiniksa Pharmaceuticals International | 10-Q: Q2 2024 Earnings Report

    Jul 25 16:16 ET

  • Kiniksa Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    Apr 25 16:22 ET

  • Kiniksa Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 28 22:32 ET

  • Kiniksa Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data